Vimovo and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimovo (esomeprazole magnesium; naproxen) and Atacand (candesartan cilexetil). Common drug interactions include death among females and abnormal behaviour among males.

The phase IV clinical study analyzes what interactions people have when they take Vimovo and Atacand. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

On Jul, 29, 2026

13 people who take Vimovo and Atacand together, and have interactions are studied.

What are the common drug interactions of Vimovo and Atacand, by gender? *:

female:

Death
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Anaemia (lack of blood)
Asthenia (weakness)
Blood pressure fluctuation
Body height decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

Abnormal behaviour
Agitation (state of anxiety or nervous excitement)
Dizziness
Drug level increased
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Dysarthria (speech disorder)
General physical health deterioration (weak health status)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
Infection
Leukocytosis (increased white blood cells)

What are the common drug interactions of Vimovo and Atacand, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Death
Abnormal behaviour
Accident at work
Agitation (state of anxiety or nervous excitement)
Ataxia (loss of full control of bodily movements)
Balance disorder
Blood creatinine increased
Carbon dioxide increased
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Depressed level of consciousness

60+:

Chronic kidney disease
Death
Confusional state
Delirium (wild excitement)
Mydriasis (a dilation of the pupil)
Urinary retention (the inability to completely or partially empty the bladder)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
Pain: 2 people, 15.38%
Upper Respiratory Tract Infection: 1 person, 7.69%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery): 1 person, 7.69%
Otitis Media Acute (rapid inflammation of the middle ear): 1 person, 7.69%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 7.69%
Muscle Tightness: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Vimovo and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously